The main objective of the Mount Sinai Liver Cancer Research Program is to maintain Mount Sinai at the forefront of hepatocellular carcinoma clinical and translational research in the US. Read More
Mount Sinai Liver Cancer Research Program
- The mission of the Mount Sinai Liver Cancer Research Program is to advance our understanding of the molecular mechanisms underlying chronic liver diseases and cancer, and to accelerate our ability to detect, treat, and cure liver cancer.
- Our Program is a recognized center for liver disease research across the spectrum of diseases (HCV, HBV, alcohol, fibrosis-cirrhosis, inflammation) with specific leadership in basic, translational, and clinical research in liver cancer.
- We are the largest US referral center for interdisciplinary management of hepatocellular carcinoma and intrahepatic cholangiocarcinoma, with more than 4,000 cases evaluated during the last 20 years. We are also a referral center for clinical research, with eight clinical trials ongoing.
Assistant, Liver Cancer Research Program
1425 Madison Avenue
New York, NY 10029
Josep M. Llovet is the Director of the HCC Program and Professor of Medicine at the Icahn School of Medicine at Mount Sinai.Learn more